Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
THE NHS England/NICE consultation on reform of the Cancer Drugs Fund closed 11/02/16.
Cancer Research UK has responded.
Sir Harpal Kumar, Cancer Research UK’s chief executive, said: “The Cancer Drugs Fund hasn’t been fit for purpose for some time so the proposed reforms are a promising step that Cancer Research UK support.
NHS England and NICE should now work to clarify details of these proposals so the system can be transformed without delay."
“We believe that making these changes will provide greater certainty to patients on the drugs that are available to them. Central to this new approach is greater discretion for the NHS to find out more about a medicine, where there’s uncertainty if it is a genuine breakthrough. We need a system that acts faster, can manage the budget and collects better data on how these drugs help patients."
“We hope that NICE and pharmaceutical companies will work together so that these changes bring life-saving drugs to patients sooner. It’s crucial that patients don’t miss out while the CDF is undergoing its changes.”
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.